Cargando…
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
Charles Preston and colleagues use case studies to describe how regulatory systems for medical products and medicines must be strengthened in low and middle income countries to assure adequate quality, safety and efficacy.
Autores principales: | Preston, Charles, Valdez, Mary Lou, Bond, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479087/ https://www.ncbi.nlm.nih.gov/pubmed/23109912 http://dx.doi.org/10.1371/journal.pmed.1001327 |
Ejemplares similares
-
Governing multisectoral action for health in low- and middle-income countries
por: Rasanathan, Kumanan, et al.
Publicado: (2017) -
Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance
por: Schar, Daniel, et al.
Publicado: (2018) -
Household Air Pollution in Low- and Middle-Income Countries: Health Risks and Research Priorities
por: Martin, William J., et al.
Publicado: (2013) -
A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries
por: Suthar, Amitabh B., et al.
Publicado: (2015) -
PRIME: A Programme to Reduce the Treatment Gap for Mental Disorders in Five Low- and Middle-Income Countries
por: Lund, Crick, et al.
Publicado: (2012)